Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
7903 items · filings · clear filters
- 8-K - MAXCYTE, INC. (0001287098) (Filer)
MaxCyte, Inc. filed a Form 8-K on October 14, 2026, reporting its results of operations and financial condition under Item 2.02, and providing financial statements and related exhibits under Item 9.01.
- 8-K - Sabre Corp (0001597033) (Filer)
Sabre Corp filed a Form 8-K on October 14, 2026, reporting the termination of a material definitive agreement and providing information under Item 8.01 regarding other events.
- 8-K - Profound Medical Corp. (0001628808) (Filer)
Profound Medical Corp. filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - WhiteHorse Finance, Inc. (0001552198) (Filer)
WhiteHorse Finance, Inc. filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - OneMedNet Corp (0001849380) (Filer)
OneMedNet Corp filed a Form 8-K with the SEC on October 14, 2026, reporting an Item 8.01 Other Events disclosure (Accession No. 0001493152-26-046931, 253 KB).
- 8-K - Fermi Inc. (0002071778) (Filer)
Fermi Inc. filed a Form 8-K on October 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits, under accession number 0001213900-26-109227.
- 8-K - Strive, Inc. (0001920406) (Filer)
Strive, Inc. filed a Form 8-K under Item 8.01 (Other Events) with the SEC on October 14, 2026, accession number 0001628280-26-065816.
- 8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)
Akebia Therapeutics, Inc. filed a Form 8-K reporting the departure of certain directors or officers and the appointment of new officers, along with disclosed compensatory arrangements for the affected officers.
- 8-K - FASTENAL CO (0000815556) (Filer)
Fastenal Co filed a Form 8-K on October 14, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.
- 8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)
Entrada Therapeutics, Inc. filed a Form 8-K with the SEC on October 14, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Cipher Digital Inc. (0001819989) (Filer)
Cipher Digital Inc. filed a Form 8-K with the SEC on October 14, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Brightline Interactive, Inc./NV (0001854445) (Filer)
Brightline Interactive, Inc. filed a Form 8-K on October 14, 2026, reporting other events and providing its financial statements and related exhibits.
- 8-K - MORGAN STANLEY (0000895421) (Filer)
Morgan Stanley filed a Form 8-K on October 14, 2026 (Accession No. 0000895421-26-000288) reporting its results of operations and financial condition, and providing its financial statements and related exhibits.
- 8-K - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Filer)
Faraday Future Intelligent Electric Inc. filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, a Regulation FD disclosure, and related financial statements and exhibits.
- 8-K - FF EAI Robotics Ecosystem Inc. (0001460702) (Filer)
FF EAI Robotics Ecosystem Inc. filed an 8-K on October 14, 2026, reporting entry into a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - STATE STREET CORP (0000093751) (Filer)
State Street Corp filed an 8-K on Oct. 14, 2026, reporting its results of operations and financial condition, changes to directors and officers, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements.
- 8-K - Karyopharm Therapeutics Inc. (0001503802) (Filer)
Karyopharm Therapeutics Inc. filed a Form 8-K with the SEC on October 14, 2026, reporting an Item 8.01 “Other Events.”
- 8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Aquestive Therapeutics filed an 8-K on October 14, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)
Eton Pharmaceuticals filed an 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, and accompanying financial statements and exhibits.
- 8-K - SONO TEK CORP (0000806172) (Filer)
Sono Tek Corp filed a Form 8-K on October 14, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.
- 8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)
Xeris Biopharma Holdings, Inc. filed a Form 8-K with the SEC on October 14, 2026, reporting under Item 8.01 (Other Events). The filing, accession number 0001867096-26-000091, is 170 KB in size.
- 8-K - ENTEGRIS INC (0001101302) (Filer)
Entegris Inc. filed a Form 8-K under Item 8.01 (Other Events) on October 14, 2026, accession number 0001101302-26-000154, with a document size of 276 KB.
- 8-K - Compass, Inc. (0001563190) (Filer)
Compass, Inc. filed an 8-K on Oct. 14, 2026 reporting departures, elections, and appointments of directors or officers, related compensatory arrangements, and providing its financial statements and exhibits.
- 8-K - XTI Aerospace, Inc. (0001529113) (Filer)
XTI Aerospace filed a Form 8-K reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)
United Therapeutics Corp filed a Form 8-K with the SEC on October 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - RANGE RESOURCES CORP (0000315852) (Filer)
Range Resources Corp filed a Form 8-K on October 14, 2026, disclosing its results of operations and financial condition for the reporting period.
- 8-K - BANK OF AMERICA CORP /DE/ (0000070858) (Filer)
Bank of America Corp filed an 8-K on October 14, 2026 (AccNo 0000070858-26-000481, 16 MB), containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.
- 8-K - Accenture plc (0001467373) (Filer)
Accenture plc filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - NATIONAL FUEL GAS CO (0000070145) (Filer)
National Fuel Gas Co filed a Form 8-K on October 14, 2026 (Accession No. 0001193125-26-420980), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - BlackRock, Inc. (0002012383) (Filer)
BlackRock, Inc. filed a Form 8-K on October 14, 2026, containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.